A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT06172478 · RECRUITING

Trial details

NCT number: NCT06172478
Sponsor: Daiichi Sankyo
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Melanoma Head and Neck Cancer Gastric Cancer Ovarian Carcinoma Cervical Cancer Endometrial Cancer Bladder Cancer Esophageal Cancer Pancreatic Carcinoma Prostate Cancer Non-small Cell Lung Cancer (NSCLC)

Start date: 2024-02-26
Primary completion: 2027-09-01
Enrollment: 740

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.